192 related articles for article (PubMed ID: 11342625)
1. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ.
Radoja S; Saio M; Frey AB
J Immunol; 2001 May; 166(10):6074-83. PubMed ID: 11342625
[TBL] [Abstract][Full Text] [Related]
2. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition.
Zaks TZ; Chappell DB; Rosenberg SA; Restifo NP
J Immunol; 1999 Mar; 162(6):3273-9. PubMed ID: 10092779
[TBL] [Abstract][Full Text] [Related]
3. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
4. Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function.
Koneru M; Schaer D; Monu N; Ayala A; Frey AB
J Immunol; 2005 Feb; 174(4):1830-40. PubMed ID: 15699109
[TBL] [Abstract][Full Text] [Related]
5. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
[TBL] [Abstract][Full Text] [Related]
6. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis.
Radoja S; Saio M; Schaer D; Koneru M; Vukmanovic S; Frey AB
J Immunol; 2001 Nov; 167(9):5042-51. PubMed ID: 11673513
[TBL] [Abstract][Full Text] [Related]
7. Treatment-enhanced CD4+Foxp3+ glucocorticoid-induced TNF receptor family related high regulatory tumor-infiltrating T cells limit the effectiveness of cytokine-based immunotherapy.
Berhanu A; Huang J; Watkins SC; Okada H; Storkus WJ
J Immunol; 2007 Mar; 178(6):3400-8. PubMed ID: 17339434
[TBL] [Abstract][Full Text] [Related]
8. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
Davidson WF; Haudenschild C; Kwon J; Williams MS
J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
[TBL] [Abstract][Full Text] [Related]
9. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
[TBL] [Abstract][Full Text] [Related]
10. Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity.
Prins RM; Incardona F; Lau R; Lee P; Claus S; Zhang W; Black KL; Wheeler CJ
J Immunol; 2004 Feb; 172(3):1602-11. PubMed ID: 14734741
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system.
Tamakawa N; Saio M; Suwa T; Ohe N; Yoshimura S; Iwama T; Shinoda J; Sakai N; Takami T
Int J Mol Med; 2004 Apr; 13(4):497-503. PubMed ID: 15010848
[TBL] [Abstract][Full Text] [Related]
12. Liver damage by infiltrating CD8+ T cells is Fas dependent.
Kennedy NJ; Russell JQ; Michail N; Budd RC
J Immunol; 2001 Dec; 167(11):6654-62. PubMed ID: 11714837
[TBL] [Abstract][Full Text] [Related]
13. Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.
Hishii M; Kurnick JT; Ramirez-Montagut T; Pandolfi F
Clin Exp Immunol; 1999 Jun; 116(3):388-94. PubMed ID: 10361224
[TBL] [Abstract][Full Text] [Related]
14. Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-gamma and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2.
Wigginton JM; Lee JK; Wiltrout TA; Alvord WG; Hixon JA; Subleski J; Back TC; Wiltrout RH
J Immunol; 2002 Oct; 169(8):4467-74. PubMed ID: 12370382
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.
Wigginton JM; Gruys E; Geiselhart L; Subleski J; Komschlies KL; Park JW; Wiltrout TA; Nagashima K; Back TC; Wiltrout RH
J Clin Invest; 2001 Jul; 108(1):51-62. PubMed ID: 11435457
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide.
Saio M; Radoja S; Marino M; Frey AB
J Immunol; 2001 Nov; 167(10):5583-93. PubMed ID: 11698429
[TBL] [Abstract][Full Text] [Related]
17. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.
Teh HS; Seebaran A; Teh SJ
J Immunol; 2000 Nov; 165(9):4814-21. PubMed ID: 11046004
[TBL] [Abstract][Full Text] [Related]
18. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
19. Intratumor gene expression after adoptive immunotherapy in a murine tumor model. Regulation of messenger RNA levels associated with the differential expansion of tumor-infiltrating lymphocytes.
Evans R; Kamdar SJ; Duffy T; Edison L
J Immunol; 1993 Jan; 150(1):177-84. PubMed ID: 8417123
[TBL] [Abstract][Full Text] [Related]
20. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
